未分化リンパ腫キナーゼ
The American Journal of Pathology 160 (4): 1487–94. (April 2002). doi:10.1016/S0002-9440(10)62574-6. PMC 1867210. PMID 11943732. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1867210/.
“Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma”. Blood 99 (12): 4540–6. (June 2002). doi:10.1182/blood.V99.12.4540. PMID 12036886.
“Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines”. International Journal of Cancer 100 (1): 49–56. (July 2002). doi:10.1002/ijc.10435. PMID 12115586.
nih.gov/pmc/articles/PMC4087770/.
↑ “Primary oesophageal Ki (CD30)-positive ALK+ anaplastic large cell lymphoma of T-cell phenotype”. Singapore Medical Journal 49 (10): e289-92. (October 2008). PMID 18946602.
1 2 “Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers”. Molecular Cancer Research 7 (9): 1466–76. (September 2009). doi:10.1158/1541-7786.MCR-08-0522. PMID 19737969.
↑ “ALK gene amplified in most inflammatory breast cancers”. Journal of the National Cancer Institute 104 (2): 87–8. (January 2012). doi:10.1093/jnci/djr553. PMID 22215853.
↑ “Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth”. The Journal of Biological Chemistry 277 (16): 14153–8.
1 2 3 “Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology”. Nature Reviews. Cancer 13 (10): 685–700. (October 2013). doi:10.1038/nrc3580. PMID 24060861.
1 2 3 “Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5)”. Proceedings of the National Academy of Sciences of the United States of America 93 (9): 4181–6. (April 1996). Bibcode: 1996PNAS...93.4181F. doi:10.1073/pnas.93.9.4181. PMC 39508. PMID 8633037. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC39508/.
1 2 3 4 “ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth”. Journal of Cell Science 117 (Pt 15): 3319–29. (July 2004). doi:10.1242/jcs.
1002/gcc.10033. PMID 12112524.
↑ “TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors”. The American Journal of Pathology 157 (2): 377–84. (August 2000). doi:10.1016/S0002-9440(10)64550-6. PMC 1850130. PMID 10934142. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1850130/.
↑ “ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients”. Modern Pathology 25 (11): 1516–25. (November 2012). doi:10.1038/modpathol.2012.107. PMID 22743654.
↑ “Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method”. Cancer 118 (18): 4427–36.